Recent

% | $
Quotes you view appear here for quick access.

Aeterna Zentaris Inc. Message Board

  • blockbusterp49 blockbusterp49 Apr 20, 2011 10:58 AM Flag

    o.t) 5 Drugs awaiting FDA approval (Mcap 47 M)=RALLYYYYYYYYYYYYYYY

    BREAKOUT STARTS ..ENJOY THE RIDE INTO DOUBLE DIGITS. GLTA

    This Unknown low float Stock awaiting 5 FDA approvals and will rise to 7 by year end .IPCI has 15 Drugs in Pipeline many nearing ANDA/NDA filing including a potential Blockbuster .

    Market Cap 47 Mil / Cash 13 M / Burn-rate 4.5 M per Year = They have enough cash to run their Company into profitable business .

    2 FDA approvals and a New Partnership coming any day now .

    MY Target is $15++ for 2011..A FANTASTIC INVESTMENT FOR BIO-FANS .


    Intellipharmaceutics (IPCI)

    Market Cap: 47 M
    Cash: 13 M
    Price: 3.05 $

    Shares Out: 15.9 Mil....(13 Mil Shares held by Insiders)



    "The filing of a generic version of Seroquel XR® is one of the Company's performance milestones for 2011 and another important addition to our product portfolio filed for approval with the FDA, which includes generics of Focalin XR®, Effexor XR®, Protonix® DR and Glucophage® XR," commented Dr. Isa Odidi, CEO of Intellipharmaceutics. "These filings not only provide further validation of our Hypermatrix™ technology, they clearly demonstrate the flexibility of our technology to efficiently and effectively match a number of drug delivery profiles."

    Intellipharmaceutics now has five ANDAs awaiting FDA approval with reported sales for branded and generic versions of these products being approximately $8 billion in 2010. The Company develops both ANDA product candidates and new drugs through the New Drug Application (NDA) 505(b)(2) regulatory pathway.

















    32e323e23e23e

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AEZS
3.44-0.07(-1.99%)Jul 22 4:00 PMEDT